Skip to content

Investigating the Effects of Synbiotic Supplements on Micronutrients after Sleeve Gastrectomy Surgery

Investigating the Effectiveness of Synbiotic Supplements on Micronutrient Status after Sleeve Gastrectomy Surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241209063999N1
Enrollment
76
Registered
2025-03-15
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Overweight and obesity

Interventions

Intervention 1: Intervention group: The synbiotic supplement BioGen®, manufactured by Tak Gene Zist, contains strains of Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus plantarum, St

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults (18 to 65 years old) who, according to NIH guidelines, have class 3 obesity or class 2 obesity with at least one obesity-related co-morbidity and have undergone SG surgery within the past month Willingness to adhere to supplement intake and follow-up programs

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients consuming other probiotic/prebiotic supplements, taking antibiotics up to 10 days before the start of the intervention, or using medications that affect gut microbiota The presence of severe malabsorption syndromes unrelated to surgery (inflammatory bowel disease, celiac disease, etc.) Presence of previous nutritional deficiencies Presence of any gastrointestinal diseases Presence of surgical complications (such as fistula at the incision site, gastrointestinal bleeding, intestinal obstruction, etc.) Unable to comprehend the purpose of evaluations or the proposed treatment Patients who refuse to participate in the study until its completion

Design outcomes

Primary

MeasureTime frame
Serum Ferritin. Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: immunoassay.;Serum Folate. Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: Radioimmunoassay.;Serum total Calcium. Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: colorimetry.;Serum 25-hydroxy vitamin D. Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: immunoassay.;Serum vitamin B12. Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: Electrochemiluminescence.;Serum Iron. Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: spectrophotometry.;TIBC (Total Iron-Binding Capacity). Timepoint: Before the start of the intervention, and 3 and 6 months after the intervention begins. Method of measurement: spectrophotometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadmahdi Abbasi

Tehran University of Medical Sciences

mm-abbasi@student.tums.ac.ir+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026